PATENT CLAIM ANALYSIS

Application Number: 16096830
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["548", "950000"]

Abstract:
Pharmaceutical compositions of the invention comprise compounds, compositions, methods useful for the treatment of drug addiction, drug withdrawal, and diseases or conditions that involve dysregulation of glutamate homeostasis in its etiology.

Claim (Index 18):
The compound of  claim 1 , wherein the compound of formula (I) is a compound having formula (XVIII): including hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 97.0
- Lexical Diversity: 1.28571
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14895681', '14781081', '14388175', '15873293', '14412050']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7183076594048659
- 35 USC 102 Novelty (BERT): 0.5650583762178724
- Combined Prediction Score: 0.7029827310861665
- Mean Citation Score: 304.931952
- Max Citation Score: 425.56122
- Similarity Product: 390.5480804859245

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test